More Globe Newswire

View Older Stories View Newer Stories

Nov 7, 2025 05:51PM Rocket Doctor Grants RSUs and Stock Options
Nov 7, 2025 05:46PM Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them
Nov 7, 2025 05:15PM Summit Royalties Announces Appointment of Jerrold Annett as Chairman; Trading to Commence on Venture Exchange; Other Corporate Updates
Nov 7, 2025 05:10PM Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01
Nov 7, 2025 05:05PM Dorel Reports Third Quarter 2025 Results
Nov 7, 2025 05:03PM Constellation Software Inc. Announces Results for the Third Quarter Ended September 30, 2025 and Declares Quarterly Dividend
Nov 7, 2025 05:02PM ASSOCIATED CAPITAL GROUP, INC. (OTCQX: ACGP) Reports Third Quarter Results
Nov 7, 2025 05:00PM GFG Closes Final Tranche of Financing
Nov 7, 2025 05:00PM Ambarella Announces Third Quarter Fiscal Year 2026 Earnings Conference Call to be Held November 25, 2025
Nov 7, 2025 05:00PM Legacy Housing Corporation Reports Third Quarter 2025 Financial and Operating Results
Nov 7, 2025 05:00PM Irreverent Warriors from Grunt Style Foundation Earns 4-Star Rating from Charity Navigator
Nov 7, 2025 04:59PM J.R. Cunningham Joins Cybersecurity Leader Cybriant as Chief Security Officer
Nov 7, 2025 04:56PM Maxus Mining Announces Closing of Flow Through Private Placement
Nov 7, 2025 04:45PM Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)
Nov 7, 2025 04:30PM Ultralife Corporation Files Form 12b-25 Notification of Late Filing
Nov 7, 2025 04:30PM Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
Nov 7, 2025 04:30PM Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 04:30PM ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 04:30PM Cornerstone Funds Announce Continuing Monthly Distributions and Reset Distribution Amounts for 2026
Nov 7, 2025 04:19PM The Experience Maker Unveils Expert Guide as U.S. Flight Reductions Put Airline Customer Experience to the Test - Expert Commentary Available
Nov 7, 2025 04:16PM CNL STRATEGIC CAPITAL ANNOUNCES OPERATING RESULTS FOR THIRD QUARTER 2025
Nov 7, 2025 04:16PM CNL STRATEGIC CAPITAL ANNOUNCES OPERATING RESULTS FOR THIRD QUARTER 2025
Nov 7, 2025 04:16PM Mueller Water Products to Participate in the Baird 2025 Global Industrial Conference
Nov 7, 2025 04:15PM NI Holdings, Inc. Reports Results for Third Quarter Ended September 30, 2025
Nov 7, 2025 04:15PM GAMCO Investors, Inc. Reports Results for the Third Quarter 2025
Nov 7, 2025 04:15PM BitMart Reframes Digital Asset Yield with the Launch of the Earn Overview Page
Nov 7, 2025 04:15PM Okeanis Eco Tankers Corp. – Invitation to Q3 2025 Results Webcast
Nov 7, 2025 04:15PM Matthews International Announces Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call
Nov 7, 2025 04:11PM Taseko to Release Third Quarter 2025 Results
Nov 7, 2025 04:10PM Cheetah Net Supply Chain Service Inc. Announces Third Quarter 2025 Results
Nov 7, 2025 04:10PM Carbon Revolution Announces Receipt of Non-Compliance Letter from Nasdaq
Nov 7, 2025 04:05PM Viasat Releases Second Quarter Fiscal Year 2026 Financial Results
Nov 7, 2025 04:05PM Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update
Nov 7, 2025 04:05PM Spyre Therapeutics Announces Grants of Inducement Awards
Nov 7, 2025 04:05PM InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria
Nov 7, 2025 04:05PM Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week
Nov 7, 2025 04:05PM Arhaus Opens Its First Montana Showroom in Bozeman
Nov 7, 2025 04:05PM BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Nov 7, 2025 04:05PM Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights
Nov 7, 2025 04:05PM Nanox to Report Third Quarter 2025 Financial Results on November 20, 2025
Nov 7, 2025 04:05PM Lithium Argentina to Release PPG Scoping Study Results with Third Quarter 2025 Earnings
Nov 7, 2025 04:05PM Mingzhu Logistic Limited Announces 1-For-16 Reverse Share Split
Nov 7, 2025 04:05PM Delisting of Securities from The Nasdaq Stock Market
Nov 7, 2025 04:05PM Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 04:01PM Senvest Capital Inc. Reports Results for the Third Quarter Ended September 30, 2025
Nov 7, 2025 04:01PM NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 04:00PM Exicure, Inc. Reports Third Quarter 2025 Financial Results
Nov 7, 2025 04:00PM British Columbia Discovery Fund Inc. (formerly British Columbia Discovery Fund (VCC) Inc.) Provides Update on Liquidation Proceedings
Nov 7, 2025 04:00PM Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 04:00PM FitLife Brands Announces Third Quarter Earnings Call
View Newer Stories View Older Stories